Global Reach Motiva Implants are approved for distribution in over 70 countries and manufactured at FDA-compliant facilities in Costa Rica, indicating strong international demand and potential for channel expansion through distributors and direct sales.

Expansion Momentum Recent launches such as Preservé in Brazil and ongoing U.S. IDE study results suggest rapid geographic and regulatory-driven growth opportunities and potential upsell of complementary products and services.

IP & Partnerships Active patent activity and ongoing litigation related to implants and surgical devices highlight opportunities to position Motiva as a premium, rights-protected platform, while pursuing strategic partnerships to deter competitors.

Healthcare Visibility Visible participation in major conferences (J.P. Morgan Healthcare Conference, The Aesthetic MEET) and robust healthtech ecosystem engagement indicate openings for speaking engagements, sponsored trials, and clinical collaborations to drive lead generation.

Financial Depth Substantial funding and mid-market revenue range with a global footprint imply capacity for large-scale procurement programs, clinical trial collaborations, and long-term contract discussions for implants, consumables, and related technologies.